Neuroone Medical Technologies (NMTC) Shares Outstanding (2010 - 2026)

Neuroone Medical Technologies (NMTC) has 17 years of Shares Outstanding data on file, last reported at $8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 64.71% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 64.71% YoY), and the FY2025 full-year result was $8.3 million, up 62.28% from the prior year.
• Shares Outstanding for Q1 2026 stood at $8.6 million, up from $8.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $49.8 million in Q2 2025 and bottomed at $5.1 million in Q3 2024.
• The 5-year median for Shares Outstanding is $16.2 million (2022), against an average of $17.2 million.
• Peak annual rise in Shares Outstanding reached 78.93% in 2025, while the deepest fall reached 80.13% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $16.2 million in 2022, then soared by 52.92% to $24.8 million in 2023, then tumbled by 79.3% to $5.1 million in 2024, then surged by 63.46% to $8.4 million in 2025, then rose by 2.54% to $8.6 million in 2026.
• The last three Shares Outstanding figures came in at $8.6 million (Q1 2026), $8.4 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.

Peer Comparison